HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Business News: PharmaSGP Makes Record Start, BioGaia Heads To Canada, Ardian Takes Nutripure Stake

Executive Summary

Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.

You may also be interested in...



BioGaia Benefits From Easing COVID Restrictions And US Launches

Swedish probiotics player BioGaia reported a big rise in sales in Q1 thanks to the end of pandemic restrictions in Europe and the growth of its operations in the US.

EU Business News: BioGaia Acquires US Distributor, Spain's Rubió Enters VMS Market, Sidefarma Gets PE Backing

Round-up of European consumer health news: Probiotics specialist BioGaia plots US expansion with acquisition of distribution partner; Spain's Rubió enters the dietary supplements space with Fisiopharma; and Portugal's Sidefarma receives investment from private-equity firm Atena.

GSK Offloads Popular German OTCs To PharmaSGP

GSK divests non-core German OTC portfolio to local player PharmaSGP, which says it has gained "established brands" in the pain-relief and sleep-aid categories.

Topics

Latest News
UsernamePublicRestriction

Register

RS152527

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel